These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 18528463

  • 1. Enhancing or eliminating signals for cell survival to treat disease.
    Tweardy DJ, Jing N.
    Trans Am Clin Climatol Assoc; 2006; 117():33-51; discussion 51-2. PubMed ID: 18528463
    [Abstract] [Full Text] [Related]

  • 2. G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis.
    Jing N, Li Y, Xiong W, Sha W, Jing L, Tweardy DJ.
    Cancer Res; 2004 Sep 15; 64(18):6603-9. PubMed ID: 15374974
    [Abstract] [Full Text] [Related]

  • 3. Prevention of hypovolemic circulatory collapse by IL-6 activated Stat3.
    Alten JA, Moran A, Tsimelzon AI, Mastrangelo MA, Hilsenbeck SG, Poli V, Tweardy DJ.
    PLoS One; 2008 Feb 13; 3(2):e1605. PubMed ID: 18270592
    [Abstract] [Full Text] [Related]

  • 4. Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer.
    Jing N, Zhu Q, Yuan P, Li Y, Mao L, Tweardy DJ.
    Mol Cancer Ther; 2006 Feb 13; 5(2):279-86. PubMed ID: 16505101
    [Abstract] [Full Text] [Related]

  • 5. T40214/PEI complex: a potent therapeutics for prostate cancer that targets STAT3 signaling.
    Weerasinghe P, Li Y, Guan Y, Zhang R, Tweardy DJ, Jing N.
    Prostate; 2008 Sep 15; 68(13):1430-42. PubMed ID: 18615483
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
    Weerasinghe P, Garcia GE, Zhu Q, Yuan P, Feng L, Mao L, Jing N.
    Int J Oncol; 2007 Jul 15; 31(1):129-36. PubMed ID: 17549413
    [Abstract] [Full Text] [Related]

  • 7. Prevention of trauma/hemorrhagic shock-induced lung apoptosis by IL-6-mediated activation of Stat3.
    Moran A, Tsimelzon AI, Mastrangelo MA, Wu Y, Yu B, Hilsenbeck SG, Poli V, Tweardy DJ.
    Clin Transl Sci; 2009 Feb 15; 2(1):41-9. PubMed ID: 20443866
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.
    Zhang X, Liu P, Zhang B, Mao H, Shen L, Ma Y.
    Int J Mol Med; 2013 Sep 15; 32(3):623-8. PubMed ID: 23828376
    [Abstract] [Full Text] [Related]

  • 9. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
    Ma H, Yan D, Wang Y, Shi W, Liu T, Zhao C, Huo S, Duan J, Tao J, Zhai M, Luo P, Guo J, Tian L, Mageta L, Jou D, Zhang C, Li C, Lin J, Lv J, Li S, Lin L.
    Cancer Sci; 2019 Mar 15; 110(3):950-961. PubMed ID: 30648776
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line.
    Johari B, Rahmati M, Nasehi L, Mortazavi Y, Faghfoori MH, Rezaeejam H.
    Cell Biol Int; 2020 Dec 15; 44(12):2499-2511. PubMed ID: 32841450
    [Abstract] [Full Text] [Related]

  • 11. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
    Canesin G, Evans-Axelsson S, Hellsten R, Sterner O, Krzyzanowska A, Andersson T, Bjartell A.
    Eur Urol; 2016 Mar 15; 69(3):400-4. PubMed ID: 26144873
    [Abstract] [Full Text] [Related]

  • 12. Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: A promising approach for eradication of cancer cells by differentiation therapy.
    Rahmati M, Johari B, Kadivar M, Rismani E, Mortazavi Y.
    J Cell Physiol; 2020 Jun 15; 235(6):5429-5444. PubMed ID: 31912904
    [Abstract] [Full Text] [Related]

  • 13. Application of decoy oligodeoxynucleotides strategy for inhibition of cell growth and reduction of metastatic properties in nonresistant and erlotinib-resistant SW480 cell line.
    Asadi Z, Fathi M, Rismani E, Bigdelou Z, Johari B.
    Cell Biol Int; 2021 May 15; 45(5):1001-1014. PubMed ID: 33377576
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H.
    Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839
    [Abstract] [Full Text] [Related]

  • 15. Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer.
    Kunigal S, Lakka SS, Sodadasu PK, Estes N, Rao JS.
    Int J Oncol; 2009 May 01; 34(5):1209-20. PubMed ID: 19360334
    [Abstract] [Full Text] [Related]

  • 16. Scoparone exerts anti-tumor activity against DU145 prostate cancer cells via inhibition of STAT3 activity.
    Kim JK, Kim JY, Kim HJ, Park KG, Harris RA, Cho WJ, Lee JT, Lee IK.
    PLoS One; 2013 May 01; 8(11):e80391. PubMed ID: 24260381
    [Abstract] [Full Text] [Related]

  • 17. Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity.
    Jeon YJ, Jung SN, Yun J, Lee CW, Choi J, Lee YJ, Han DC, Kwon BM.
    Cancer Sci; 2015 Apr 01; 106(4):413-20. PubMed ID: 25611086
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
    Zhang X, Zhang J, Wang L, Wei H, Tian Z.
    BMC Cancer; 2007 Aug 04; 7():149. PubMed ID: 17683579
    [Abstract] [Full Text] [Related]

  • 19. Combined treatment targeting HIF-1α and Stat3 is a potent strategy for prostate cancer therapy.
    Reddy KR, Guan Y, Qin G, Zhou Z, Jing N.
    Prostate; 2011 Dec 04; 71(16):1796-809. PubMed ID: 21480310
    [Abstract] [Full Text] [Related]

  • 20. Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.
    Yousuf S, Duan M, Moen EL, Cross-Knorr S, Brilliant K, Bonavida B, LaValle T, Yeung KC, Al-Mulla F, Chin E, Chatterjee D.
    PLoS One; 2014 Dec 04; 9(3):e92478. PubMed ID: 24658061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.